help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on August 11, 2004, doi:10.1164/rccm.200404-533OC

Am. J. Respir. Crit. Care Med., Volume 170, Number 11, December 2004, 1153-1157

A more recent version of this article appeared on December 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200404-533OCv1
170/11/1153    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fanucchi, M. V
Right arrow Articles by Miller, L. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fanucchi, M. V
Right arrow Articles by Miller, L. A

Submitted on May 11, 2004
Accepted on August 6, 2004

Immunostimulatory Oligonucleotides Attenuate Airways Remodelling in Allergic Monkeys

Michelle V Fanucchi1*, Edward S Schelegle1, Gregory L Baker1, Michael J Evans1, Ruth J McDonald1, Laurel J Gershwin1, Eyal Raz2, Dallas M Hyde1, Charles G Plopper1, and Lisa A Miller1

1 Center for Comparative Respiratory Biology and Medicine, California Primate Research Center, University of California, Davis, CA, USA, 2 School of Medicine, University of California, San Diego, CA, USA

* To whom correspondence should be addressed. E-mail: mvfanucchi{at}ucdavis.ed.

To determine whether inhaled immunostimulatory DNA sequence oligonucleotides containing CpG motifs mitigate the pathophysiologic manifestation of the asthmatic phenotype (airways hyperresponsiveness and airways remodelling), rhesus monkeys with experimentally-induced allergic airways disease were treated seven times with inhaled immunostimulatory oligonucleotides (or sham) periodically for 33 weeks. Airways hyperresponsiveness was reduced 2-fold in immunostimulatory DNA sequence-treated compared to sham-treated monkeys. Airways from immunostimulatory oligonucleotide-treated monkeys had thinner reticular basement membranes, fewer mucous cells, fewer eosinophils, and fewer mast cells than sham-treated allergic monkeys. We conclude that inhaled immunostimulatory oligonucleotides can attenuate the magnitude of airway hyperreactivity and airways remodelling produced in non-human primates with experimentally-induced allergic airways disease.
Key words: immunostimulatory DNA sequence oligonucleotides, allergic asthma, airway wall alterations, non-human primate




This article has been cited by other articles:


Home page
 J. Immunol.Home page
H. Constabel, M. V. Stankov, C. Hartwig, T. Tschernig, and G. M. N. Behrens
Impaired Lung Dendritic Cell Migration and T Cell Stimulation Induced by Immunostimulatory Oligonucleotides Contribute to Reduced Allergic Airway Inflammation
J. Immunol., September 1, 2009; 183(5): 3443 - 3453.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
N. W. J. Schroder and M. Arditi
IEIIS Meeting minireview: The role of innate immunity in the pathogenesis of asthma: evidence for the involvement of Toll-like receptor signaling
Innate Immunity, October 1, 2007; 13(5): 305 - 312.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
C. M. Lloyd and D. S. Robinson
Allergen-induced airway remodelling
Eur. Respir. J., May 1, 2007; 29(5): 1020 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Shan, A. Hu, H. Veler, S. Fatma, J. S. Grunstein, S. Chuang, and M. M. Grunstein
Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L324 - L333.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. M. Gauvreau, E. M. Hessel, L.-P. Boulet, R. L. Coffman, and P. M. O'Byrne
Immunostimulatory Sequences Regulate Interferon-inducible Genes but not Allergic Airway Responses
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 15 - 20.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Bergeron and L.-P. Boulet
Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation.
Chest, April 1, 2006; 129(4): 1068 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
E. M. Hessel, M. Chu, J. O. Lizcano, B. Chang, N. Herman, S. A. Kell, M. Wills-Karp, and R. L. Coffman
Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction
J. Exp. Med., December 5, 2005; 202(11): 1563 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
R. L. Coffman and E. M. Hessel
Nonhuman primate models of asthma
J. Exp. Med., June 20, 2005; 201(12): 1875 - 1879.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Hayashi, X. Gong, C. Rossetto, C. Shen, K. Takabayashi, V. Redecke, H. Spiegelberg, D. Broide, and E. Raz
Induction and Inhibition of the Th2 Phenotype Spread: Implications for Childhood Asthma
J. Immunol., May 1, 2005; 174(9): 5864 - 5873.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 686 - 698.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society 		  ATS 2008 State of the Art Course